Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (24)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by van Ittersum, F. J.
Right arrow Articles by Stehouwer, C. D. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by van Ittersum, F. J.
Right arrow Articles by Stehouwer, C. D. A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nephrol Dial Transplant (2000) 15: 1000-1007
© 2000 European Renal Association-European Dialysis and Transplant Association

Genetic polymorphisms of the renin–angiotensin system and complications of insulin-dependent diabetes mellitus

Frans J. van Ittersum1,, Angelique M. E. de Man1, Sandra Thijssen2, Peter de Knijff2, Eline Slagboom2, Yvo Smulders1, Lise Tarnow3, Ab J. M. Donker1, Henk J. G. Bilo4 and Coen D. A. Stehouwer1

1 Department of Medicine, Institute for Cardiovascular Research, Vrije Universiteit Amsterdam, The Netherlands, 2 Gaubius Laboratory TNO-PG, Leiden, The Netherlands, 3 Steno Diabetes Center, Gentofte, Denmark and 4 Department of Internal Medicine, Isala Clinics, Weezenlanden Location, Zwolle, The Netherlands

Objective. Patients with insulin-dependent diabetes mellitus (IDDM) have a high risk of developing diabetic nephropathy, retinopathy and cardiovascular diseases. The contribution of gene polymorphisms of the renin angiotensin system to these complications is controversial and may differ among populations.

Methods. In 257 Dutch IDDM patients (188 with urinary albumin excretion (UAE) <30 mg/24 h), logistic regression analysis was used to study the relationships among, on the one hand, the insertion/deletion gene polymorphism of the angiotensin-converting enzyme gene (ACE-ID), the M235T gene polymorphism of the angiotensinogen gene (AGT-M235T), and the A1166C gene polymorphism of the angiotensin type 1 receptor gene (AT1-A1166C), and, on the other hand, UAE, retinopathy, hypertension, and coronary heart disease.

Results. The T-allele of the AGT-M235T polymorphism was associated with an increased risk of an elevated UAE (odds ratio (OR) 3.03; 95% confidence interval (CI) 1.06–8.61), but only when interaction with the D-allele of the ACE-ID polymorphism was considered. A previously described positive interaction between the T-allele of the AGT-M235T polymorphism and the D-allele of the ACE-ID polymorphism could not be confirmed. The T-allele was also associated with an increased risk of retinopathy (OR 3.89, 95% CI 1.79–8.47). The CC-genotype of the AT1-A1166C polymorphism was associated with hypertension (OR 3.58; 95% CI 1.23–10.37).

Conclusions. In a Dutch IDDM population, including 69 patients with (incipient) diabetic nephropathy, the T-allele of the AGT-M235T polymorphism is associated with an elevated UAE and diabetic retinopathy and the CC-genotype of the AT1-A1166C polymorphism is associated with hypertension. A previously described interaction between the AGT-M235T and the ACE-ID polymorphisms could not be confirmed. Since the number of nephropathic patients in this study is small, these conclusions must be interpreted with caution.

Keywords: insulin-dependent diabetes mellitus; complications; angiotensin-converting enzyme gene polymorphism; angiotensinogen gene polymorphism; angiotensin II type 1 receptor gene polymorphism

Correspondence and offprint requests to: F. J. van Ittersum MD, Department of Nephrology, Academisch Ziekenhuis Vrije Universiteit, De Boelelaan 1117, NL-1081 HV Amsterdam, The Netherlands.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
DiabetesHome page
A. Kretowski, K. McFann, J. E. Hokanson, D. Maahs, G. Kinney, J. K. Snell-Bergeon, R. P. Wadwa, R. H. Eckel, L. Ogden, S. Garg, et al.
Polymorphisms of the Renin-Angiotensin System Genes Predict Progression of Subclinical Coronary Atherosclerosis
Diabetes, March 1, 2007; 56(3): 863 - 871.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
T. J. Orchard, T. Costacou, A. Kretowski, and R. W. Nesto
Type 1 diabetes and coronary artery disease.
Diabetes Care, November 1, 2006; 29(11): 2528 - 2538.
[Full Text] [PDF]


Home page
Am J EpidemiolHome page
T. Costacou, Y. Chang, R. E. Ferrell, and T. J. Orchard
Identifying Genetic Susceptibilities to Diabetes-related Complications among Individuals at Low Risk of Complications: An Application of Tree-Structured Survival Analysis
Am. J. Epidemiol., November 1, 2006; 164(9): 862 - 872.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
S. Schon, C. Prante, C. Bahr, L. Tarnow, J. Kuhn, K. Kleesiek, and C. Gotting
The Xylosyltransferase I Gene Polymorphism c.343G>T (p.A125S) Is a Risk Factor for Diabetic Nephropathy in Type 1 Diabetes
Diabetes Care, October 1, 2006; 29(10): 2295 - 2299.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
A. Jones, S. S. Dhamrait, J. R. Payne, E. Hawe, P. Li, I. S. Toor, L. Luong, P. T.E. Wootton, G. J. Miller, S. E. Humphries, et al.
Genetic Variants of Angiotensin II Receptors and Cardiovascular Risk in Hypertension
Hypertension, October 1, 2003; 42(4): 500 - 506.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
P. H. Lane
Diabetic kidney disease: impact of puberty
Am J Physiol Renal Physiol, October 1, 2002; 283(4): F589 - F600.
[Abstract] [Full Text] [PDF]


Home page
AAP Grand RoundsHome page
A. L. Friedman
Predictors of Nephropathy in Type 1 Diabetes
AAP Grand Rounds, July 1, 2002; 8(1): 4 - 5.
[Full Text] [PDF]


Home page
DiabetesHome page
J. E. Hokanson, S. Cheng, J. K. Snell-Bergeon, B. A. Fijal, M. A. Grow, C. Hung, H. A. Erlich, J. Ehrlich, R. H. Eckel, and M. Rewers
A Common Promoter Polymorphism in the Hepatic Lipase Gene (LIPC-480C>T) Is Associated With an Increase in Coronary Calcification in Type 1 Diabetes
Diabetes, April 1, 2002; 51(4): 1208 - 1213.
[Abstract] [Full Text] [PDF]


Home page
QJMHome page
C.W. Gradden, P. Pai, P. Hindell, D.J. O'Donoghue, H. Mason, and G.M. Bell
Membranous nephropathy, hydrocarbon exposure and genetic variants of hydrocarbon detoxification
QJM, February 1, 2001; 94(2): 79 - 87.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.